Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 151056
Gene Symbol: PLB1
PLB1
0.010 AlteredExpression disease BEFREE In patients with MN, levels of IgG1, IgG4, C3, C4a and phospholipase-A2-receptor were significantly elevated in comparison to the controls, as were the aforementioned factors related to oxidative stress and cell proliferations detected in IgAN. 31707756 2020
Entrez Id: 7534
Gene Symbol: YWHAZ
YWHAZ
0.010 AlteredExpression disease BEFREE In patients with MN, levels of IgG1, IgG4, C3, C4a and phospholipase-A2-receptor were significantly elevated in comparison to the controls, as were the aforementioned factors related to oxidative stress and cell proliferations detected in IgAN. 31707756 2020
Entrez Id: 939
Gene Symbol: CD27
CD27
0.010 AlteredExpression disease BEFREE The potential relationship between variants was analyzed.<b>Results</b>: In comparison with the HC, the frequency of CD3-CD19+ CD27+ IgD+IgM+ non-switched memory B cells (<i>P</i> = .0038) and CD3-CD19+ CD27hiCD38hi plasmablasts (<i>P</i> = .0467) and serum IL-6 (<i>P</i> = .0392) levels significantly increased in IgAN patients. 31670996 2020
Entrez Id: 5319
Gene Symbol: PLA2G1B
PLA2G1B
0.010 AlteredExpression disease BEFREE In patients with MN, levels of IgG1, IgG4, C3, C4a and phospholipase-A2-receptor were significantly elevated in comparison to the controls, as were the aforementioned factors related to oxidative stress and cell proliferations detected in IgAN. 31707756 2020
Entrez Id: 3603
Gene Symbol: IL16
IL16
0.010 GeneticVariation disease BEFREE Our study demonstrated that IL-16 rs859 (OR = 0.75, p = 0.040) and CYP19A1 rs4646 (OR = 2.58, p = 0.017) polymorphism were related to the risk of IgAN. 31067541 2019
Entrez Id: 3703
Gene Symbol: STT3A
STT3A
0.010 Biomarker disease BEFREE IgA production from IgAN-TMCs was inhibited by APRIL neutralization antibody or TACI blocking antibody, and enhanced by co-treatment of APRIL and CpG-ODN. 31088610 2019
Entrez Id: 10598
Gene Symbol: AHSA1
AHSA1
0.010 AlteredExpression disease BEFREE Assessment of kidney biopsy specimens from IgA nephropathy patients revealed that the degree of interstitial fibrosis was significantly associated with the tissue immunoactivity of phosphorylated p38. 30897126 2019
Entrez Id: 25897
Gene Symbol: RNF19A
RNF19A
0.010 AlteredExpression disease BEFREE Assessment of kidney biopsy specimens from IgA nephropathy patients revealed that the degree of interstitial fibrosis was significantly associated with the tissue immunoactivity of phosphorylated p38. 30897126 2019
Entrez Id: 54522
Gene Symbol: ANKRD16
ANKRD16
0.010 GeneticVariation disease BEFREE In the replication cohort, rs2296136 in ANKRD16 was significantly associated with IgAN (odds ratio [OR] = 1.40, 95% confidence interval [CI] 0.99-1.98, p = 0.05 in log-additive model, OR = 1.55, 95% CI = 1.06--2.27, p = 0.02 in dominant model, and OR = 0.70, 95% CI = 0.17--2.84, p = 0.62 in recessive model). rs2296136 in ANKRD16 also showed a significant association with IgAN in the entire study population combining GWAS and replication study (p = 0.0045 in log-additive model, p = 0.0027 in dominant model, and p = 0.76 in recessive model). 31426789 2019
Entrez Id: 4358
Gene Symbol: MPV17
MPV17
0.010 GeneticVariation disease BEFREE Crescents and Global Glomerulosclerosis in Chinese IgA Nephropathy Patients: A Five-Year Follow-Up. 30808856 2019
Entrez Id: 406942
Gene Symbol: MIR150
MIR150
0.010 AlteredExpression disease BEFREE Among the 8 miRNA targets chosen for validation study, urinary miR-204, miR-431 and miR-555 remained significantly reduced, and urinary miR-150 level was significantly increased in the IgAN as compared to CTL. 30832601 2019
Entrez Id: 23495
Gene Symbol: TNFRSF13B
TNFRSF13B
0.010 AlteredExpression disease BEFREE These findings suggest that APRIL is involved in the hyperproduction of IgA from IgAN-TMCs, and that CpG-ODN enhanced APRIL-induced IgA production by increasing TACI expression on B-cells of IgAN-TMCs. 31088610 2019
Entrez Id: 5741
Gene Symbol: PTH
PTH
0.010 GeneticVariation disease BEFREE Logistics regression analysis showed that middle and elderly age, elevated P, intact parathyroid hormone and TT genotype were independent risk factors for renal dysfunction in IgAN patients; the odds ratio of carrying the TT genotype was as high as 84.77 (<i>P</i> < 0.05 for all). 31218132 2019
Entrez Id: 26503
Gene Symbol: SLC17A5
SLC17A5
0.010 Biomarker disease BEFREE Compared to patients with IgAN-NSD, those with IgAN-SD had significantly lower mean serum protein (6.4 g/dL vs. 6.7 g/dL; p = 0.02), albumin (3.7 g/dL vs. 3.9 g/dL; p = 0.02), and complement (C3) (94 mg/dL vs. 103 mg/dL; p = 0.02) levels. 30785896 2019
Entrez Id: 3093
Gene Symbol: UBE2K
UBE2K
0.010 AlteredExpression disease BEFREE Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy. 31057023 2019
Entrez Id: 23072
Gene Symbol: HECW1
HECW1
0.010 AlteredExpression disease BEFREE And HECW1 mRNA expression had a significant inverse correlation with Gd-IgA1 levels in IgAN patients (r= -0.34, p = .03). 31057023 2019
Entrez Id: 3148
Gene Symbol: HMGB2
HMGB2
0.010 Biomarker disease BEFREE The DEGs (differentially expressed genes)-miRNA network that was associated with IgAN was constructed by Cytoscape, and HMGB2 and hsa-miR-590-3p were selected for further exploration. 31557418 2019
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.010 GeneticVariation disease BEFREE We investigated the relationship between <i>VDR FokI</i> (rs2228570) single nucleotide polymorphism (SNP) and renal function and related clinicopathologic parameters in IgAN patients. 31218132 2019
Entrez Id: 8864
Gene Symbol: PER2
PER2
0.010 GeneticVariation disease BEFREE Membranous nephropathy (29.1%) was the most common pathological finding in the entire study population, followed by IgA nephropathy (23.4%), minimal change disease (12.7%), and mesangio-proliferative glomerulonephritis (7.4%).We divided the study period into 2 subperiods: 2007 to 2011 (period 1) and 2012 to 2016 (period 2). 31169695 2019
Entrez Id: 7439
Gene Symbol: BEST1
BEST1
0.010 Biomarker disease BEFREE In this study, we summarized currently available evidence from randomized controlled trials (RCTs) that evaluated the effect of ACEI/ARB therapy of IgAN. 30270542 2019
Entrez Id: 8793
Gene Symbol: TNFRSF10D
TNFRSF10D
0.010 Biomarker disease BEFREE Renal DcR2 co-localized with α-SMA and collagen III in the kidneys of IgAN patients. 31487717 2019
Entrez Id: 64759
Gene Symbol: TNS3
TNS3
0.010 GeneticVariation disease BEFREE In this study, we aimed to explore the role of TNS3, PHLDB1, NTN4, and GNG2 3'untranslated region (3'UTR) polymorphisms with the risk of IgAN in a Chinese Han cohort. 30928649 2019
Entrez Id: 1432
Gene Symbol: MAPK14
MAPK14
0.010 AlteredExpression disease BEFREE Assessment of kidney biopsy specimens from IgA nephropathy patients revealed that the degree of interstitial fibrosis was significantly associated with the tissue immunoactivity of phosphorylated p38. 30897126 2019
Entrez Id: 1981
Gene Symbol: EIF4G1
EIF4G1
0.010 Biomarker disease BEFREE UBL4A and EIF4G1 were the two most important DEG for MN because they were downregulated compared with both control and IgAN groups. 30084529 2019
Entrez Id: 22936
Gene Symbol: ELL2
ELL2
0.010 AlteredExpression disease BEFREE Consistent with present results, the lower ELL2 expression in IgAN patients was observed in microarray expression profiles from GEO datasets. 31275443 2019